Track StemCell Institute's inventory ($76M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest inventory for 7096.T is $76M as of September 2026. That compares with $58M in the prior-year period — up 31.1% year over year. Investors often review this figure alongside StemCell Institute's historical trend and sector peers before judging valuation or financial health.
Over the past year, 7096.T's inventory moved from $58M to $76M — a 31.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in StemCell Institute's operating scale or balance-sheet position.
A inventory figure of $76M for 7096.T is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 7096.T's inventory ($76M), review year-over-year change from $58M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack StemCell Institute's inventory against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.